Back to mobile site

Canaccord Genuity Lower PT & Estimates on Greatbatch, Inc. (GB); In-line Q2; Stagnant Operating Margin

July 26, 2012 1:51 PM EDT
Get Alerts GB Hot Sheet
Price: $7.49 --0%

Rating Summary:
    2 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Canaccord Genuity maintains a 'Hold' on Greatbatch, Inc. (NYSE: GB) price target of $25.00 (from $27.00).

Analyst, Jason R. Mills, said, "GB saw a modest improvement in CRM and continued strength in Vascular and ElectroChem, offset by weakness in Orthopedics, which management said would not hit its 2012 targets due to FX headwinds and operational issues. Operating margin leverage has stagnated around 12% for the past three years albeit improved to 11.5% (pro forma) in Q2 from 9.8% in Q1. While we continue to have a favorable view of the company’s long-term medical device product strategy, we do not see OM expansion potential near term." (Lowers FY13 EPS estimate from $2.01 to $1.97)

For an analyst ratings summary and ratings history on Greatbatch, Inc. click here. For more ratings news on Greatbatch, Inc. click here.

Shares of Greatbatch, Inc. closed at $22.48 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Canaccord Genuity